Stocks · Health care · Services-Medical Laboratories

Fulgent Genetics, Inc.

FLGT Clue Score31
United States Fiscal year ends December CIK 0001674930 Results filed 5 Nov 2026

What the insiders did Net selling

By person

11 insiders · 178 transactions
52.0×

Ming Hsieh holds 52.0 times base salary in stock. $52.02M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Ming Hsieh last reported holding, valued at $19.66, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Paul Kim
CFO and Treasurer
$1.60M (1)
$18.39M (57)
−$16.80M
353,795
1.29%
$6.95M
−10.5%
Jian Xie
President and COO
—
$10.77M (55)
−$10.77M
797,195
2.90%
$15.67M
+29.7%
John C Bolger
Director
—
$1.23M (15) scheduled
−$1.23M
5,100
0.0185%
$100.25K
−25.5%
Hanlin Gao
Chief Scientific Officer
—
$680.30K (30)
−$680.30K
984,472
3.58%
$19.35M
−44.3%
Ming Hsieh
Chief Executive Officer
$558.57K (18)
$93.48K (2)
+$465.10K
2,646,373
9.62%
$52.02M
+88.6%
Linda Dong
Director
—
—
—
38,758
0.1409%
$761.84K
—
Regina E Groves
Director
—
—
—
28,099
0.1021%
$552.33K
—
Michael Nohaile
Director
—
—
—
24,578
0.0893%
$483.11K
—
Leonard E Post
Director
—
—
—
8,000
0.0291%
$157.25K
—
Fulgent Genetics, Inc. entity
Director
—
—
—
6,842
0.0249%
$134.49K
+140.7%
Yun Yen
Director
—
—
—
2,000
0.0073%
$39.31K
−99.6%